Galmed Pharmaceuticals Ltd. buy Roth Mkm
Start price
20.10.23
/
50%
€0.39
Target price
20.10.24
€70.85
Performance (%)
-38.34%
Price
29.08.24
€0.24
Summary
This prediction is currently active. The BUY prediction by Roth_Mkm for Galmed Pharmaceuticals Ltd. is performing very badly with a performance of -38.34%. This prediction currently runs until 20.10.24. The prediction end date can be changed by Roth_Mkm at any time. Roth_Mkm has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Galmed Pharmaceuticals Ltd. | -34.225% | -34.225% |
iShares Core DAX® | 1.743% | 1.903% |
iShares Nasdaq 100 | -2.088% | -0.640% |
iShares Nikkei 225® | 1.306% | 4.161% |
iShares S&P 500 | -0.093% | 0.169% |
Comments by Roth_Mkm for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) is now covered by analysts at Roth Mkm. They set a "buy" rating and a $75.00 price target on the stock.
Ratings data for GMED provided by MarketBeat